收稿日期: 2021-03-02
修回日期: 2021-04-23
网络出版日期: 2021-06-23
基金资助
上海市自然科学基金(20ZR1463600);寄生虫病所防治技术储备科研基金(CB2020-8)
Affect of aminoalcohol compound HT24 on the expression of tubulin in Echinococcus multilocularis protoscoleces
Received date: 2021-03-02
Revised date: 2021-04-23
Online published: 2021-06-23
Supported by
Natural Science Fundation of Shanghai(20ZR1463600);Research Fundation for the Control Technology Reserve of National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention(CB2020-8)
目的 探索氨基醇类化合物HT24对多房棘球蚴原头节微管蛋白表达水平的影响。方法 从感染多房棘球蚴的BALB/c小鼠体内分离原头节,体外培养1 d后分为对照组和低、中、高浓度组,分别加入终浓度0.5%的二甲基亚砜(DMSO)和25、50、100 μmol/L的HT24共培养,每组设3个平行孔,每孔含原头节约2 000个。HT24作用后第1~3 天观察虫体活性及形态改变,第3天透射电镜下观察原头节焰细胞超微结构的变化情况,第3、5、7 天实时荧光定量PCR(qPCR)检测原头节中α9-,β2-,β4-和β6-微管蛋白基因的mRNA相对转录水平,蛋白质免疫印迹(Western blotting)检测原头节中β-微管蛋白的相对表达量。组间比较使用双因素方差分析方法。结果 氨基醇类化合物HT24作用后第3天,低浓度组多房棘球蚴原头节轮廓模糊,虫体胀大,透明度降低,部分钩突脱落;中浓度组原头节明显胀大,钩突脱落;高浓度组原头节全部死亡,虫体缩小。透射电镜观察结果显示,中、高浓度组焰细胞胞膜破裂,胞质内纤毛断裂,出现大的缺口或断裂口,部分纤毛溢出,游离于细胞外。qPCR结果显示,相较于对照组(100),低、中、高浓度组第7天α9-微管蛋白基因mRNA相对转录水平分别为8.01 ± 1.54、9.84 ± 0.40和7.85 ± 2.60,3组间差异有统计学意义(P < 0.01);β2-微管蛋白基因mRNA相对转录水平分别为10.97 ± 0.69、11.83 ± 0.97 和6.48 ± 1.52,3组间差异有统计学意义(P < 0.01);β4-微管蛋白基因mRNA相对转录水平分别为10.61 ± 1.24、8.31 ± 1.05 和7.47 ± 0.96,3组间差异有统计学意义(P < 0.01);β6-微管蛋白基因mRNA相对转录水平分别为8.83 ± 0.80、7.89 ± 1.30 和5.63 ± 2.25,3组间差异有统计学意义(P < 0.01)。Western blotting分析结果显示,HT24作用后第3 天低、中、高浓度组β-微管蛋白的相对表达量分别为0.36 ± 0.06、0.23 ± 0.03和0.61 ± 0.06,均低于对照组(0.67 ± 0.05)(P < 0.01);第5 天分别为1.12 ± 0.03,0.55 ± 0.04,0.30 ± 0.02,均高于对照组(0.26 ± 0.03)(P < 0.01);第7 天分别为0.73 ± 0.05,0.36 ± 0.04,0.40 ± 0.04,其中中、高浓度组低于对照组(0.73 ± 0.05)(P < 0.01)。结论 氨基醇类化合物HT24能降低多房棘球蚴原头节微管蛋白基因mRNA和蛋白的表达水平,影响微管蛋白功能,从而抑制多房棘球蚴的生存。
史琦琪 , 刘丛珊 , 霍乐乐 , 魏玉芬 , 姜斌 , 殷梦 , 薛剑 , 陶奕 , 张皓冰 . 氨基醇类化合物HT24对多房棘球蚴原头节微管蛋白表达水平的影响[J]. 中国寄生虫学与寄生虫病杂志, 2021 , 39(4) : 437 -443 . DOI: 10.12140/j.issn.1000-7423.2021.04.003
Objective To understand the affect of aminoalcohol compound HT24 on the expression of tubulin in Echinococcus multilocularis protoscoleces. Methods Protoscoleces were isolated from BALB/c mice infected with E. multilocularis metacestode, and cultured in vitro for 1 day. Then they were assigned into groups of low, medium and high concentration of HT24 treatment, which were added with 0.5% DMSO (control group) and 25 μmol/L, 50 μmol/L or 100 μmol/L HT24, respectively. Each group was set with 3 replicates, and 2 000 protoscoleces in each well. The viability and morphological changes of the protoscoleces were observed in first 3 days after addition of HT24. Samples were collected on the third day and subjected to transmission electron microscopy (TEM) to observe the ultrastructural changes of flame cells. Samples were collected at 3, 5, and 7 days for real-time fluorescence quantitative PCR (qPCR) to examine the mRNA expression levels of α9-, β2-, β4- and β6-tubulin, and Western blotting to examine the protein levels of β-tubulin. Two-way ANOVA was applied for between-group comparisons. Results After 3 days of HT24 treatment, in the low-concentration group, the E. multilocularis protoscoleces had unclear outline, swollen body, decreased transparency, and detachment of some hooks. In the medium-concentration group, the protoscoleces were obviously enlarged and hooks were detached. All protoscoleces in the high-concentration group died and dwindled in size. TEM showed that in the medium- and high-concentration groups, the membranes of flame cells were broken, ciliary in the cytoplasm ruptured with large notches or fracture openings, and some cilia spilled out and were free outside the cells. qPCR showed that compared to the control group, the mRNA expression of α9-tubulin on day 7 in the low-, medium- and high-concentration groups was 8.01 ± 1.54, 9.84 ± 0.40 and 7.85 ± 2.60, respectively, there was significant difference between the 3 groups (P < 0.01); the mRNA expression of β2-tubulin in the low-, medium- and high-concentration group on day 7 was 10.97 ± 0.69,11.83 ± 0.97 and 6.48 ± 1.52, respectively, there was significant difference between the 3 groups (P < 0.01); the mRNA expression of β4-tubulin on day 7 in the low-, medium- and high-concentration groups was 10.61 ± 1.24, 8.31 ± 1.05 and 7.47 ± 0.96, respectively, there was significant difference between the 3 groups (P < 0.01); the mRNA expression of β6-tubulin on day 7 was 8.83 ± 0.80, 7.89 ± 1.30 and 5.63 ± 2.25 in the low-, medium- and high-concentration groups, respectively, there was significant difference between the 3 groups (P < 0.01). Western blotting results showed that on day 3 after treatment, the β-tubulin protein levels at the low-, medium- and high-concentration groups were 0.36 ± 0.06, 0.23 ± 0.03, and 0.61 ± 0.06, respectively, all lower than the control group (0.67 ± 0.05) (P < 0.01); on day 5 after treatment, the β-tubulin protein levels in the low-, medium- and high-concentration groups were 1.12 ± 0.03, 0.55 ± 0.04, and 0.30 ± 0.02, respectively, all higher than the control group (0.26 ± 0.03) (P < 0.01); on day 7 after treatment, they were 0.73 ± 0.05, 0.36 ± 0.04, and 0.40 ± 0.04, respectively, The latter two were lower than control group (0.73 ± 0.05) (P < 0.01). Conclusion HT24 can lower the mRNA and protein levels of β-tubulin and affect the function of microtubules, thereby suppressing the viability of E. multilocularis metacestodes.
Key words: Echinococcus multilocularis; Amino alcohols; Protoscoleces; Tubulin
| [1] | Wang LY, Wu WP. Natural factors of alveolar echinococcosis[J]. Chin J Zoonoses, 2009, 25(1):63-66. (in Chinese) |
| [1] | (王立英, 伍卫平. 泡球蚴病流行的自然因素[J]. 中国人兽共患病学报, 2009, 25(1):63-66.) |
| [2] | Eckert J, Gemmell MA, Meslin FX, et al. WHO/OIE manual on echinococcosis in human and animals: a public health problem of global concern[M]. Paris: World Organization for Animal Health, 2001: 1-17. |
| [3] | Holmes P. Investing to overcome the global impact of neglected tropical diseases[R]. Geneva: WHO, 2015, 7(4244):596-596. |
| [4] | Food and Agriculture Organization of the United Nations/World Health Organization. Multicriteria-based ranking for risk management of food borne parasites[R]. Rome: FAO Headquarters, 2012. |
| [5] | Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern[J]. Clin Microbiol Rev, 2004, 17(1):107-135. |
| [6] | Ammann RW, Eckert J. Cestodes. Echinococcus[J]. Gastroenterol Clin North Am, 1996, 25(3):655-689. |
| [7] | WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans[J]. Bull World Health Organ, 1996, 74(3):231-242. |
| [8] | Kern P, Menezes da Silva A, Akhan O, et al. The echinococcoses: diagnosis, clinical management and burden of disease[J]. Adv Parasitol, 2017, 96:259-369. |
| [9] | Jura H, Bader A, Frosch M. In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes[J]. Antimicrob Agents Chemother, 1998, 42(5):1052-1056. |
| [10] | Reuter S, Jensen B, Buttenschoen K, et al. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature[J]. J Antimicrob Chemother, 2000, 46(3):451-456. |
| [11] | Reuter S, Buck A, Manfras B, et al. Structured treatment interruption in patients with alveolar echinococcosis[J]. Hepatology, 2004, 39(2):509-517. |
| [12] | Zhu WJ, Han XM, Guo YM. Progress in researches of benzimidazole in treatment of echinococcosis[J]. Chin J Schisto Control, 2017, 29(4):530-533. (in Chinese) |
| [12] | (朱文君, 韩秀敏, 郭亚民. 苯并咪唑类药物治疗包虫病研究进展[J]. 中国血吸虫病防治杂志, 2017, 29(4):530-533.) |
| [13] | Liu C, Yin J, Xue J, et al. In vitro effects of amino alcohols on Echinococcus granulosus[J]. Acta Trop, 2018, 182:285-290. |
| [14] | Brehm K, Kronthaler K, Jura H, et al. Cloning and characterization of beta-tubulin genes from Echinococcus multilocularis[J]. Mol Biochem Parasitol, 2000, 107(2):297-302. |
| [15] | Pierce RJ, Dubois-Abdesselem F, Lancelot J, et al. Targeting schistosome histone modifying enzymes for drug development[J]. Curr Pharm Des, 2012, 18(24):3567-3578. |
| [16] | Parker AL, Teo WS, McCarroll JA, et al. An emerging role for tubulin isotypes in modulating cancer biology and chemotherapy resistance[J]. Int J Mol Sci, 2017, 18(7):1434. |
| [17] | Nogales E. Structural insight into microtubule function[J]. Annu Rev Biophys Biomol Struct, 2001, 30:397-420. |
| [18] | Subramanian R, Kapoor TM. Building complexity: insights into self-organized assembly of microtubule-based architectures[J]. Dev Cell, 2012, 23(5):874-885. |
| [19] | Mao J, Wang D, Wang Z, et al. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway[J]. Cancer Lett, 2016, 380(1):134-143. |
| [20] | Liu M, Zhu YQ, Huang JF, et al. Ubiquitin-conjugating enzyme E2C regulates the progression of hepatocellular carcinoma by specifically binding to β-tubulin[J]. Acad J Second Mil Med Univ, 2021, 42(1):14-20. (in Chinese) |
| [20] | (刘梦, 朱怡卿, 黄金凤, 等. 泛素结合酶E2C通过特异性结合β-微管蛋白参与调控肝细胞癌进展[J]. 第二军医大学学报, 2021, 42(1):14-20.) |
| [21] | Froidevaux-Klipfel L, Poirier F, Boursier C, et al. Modulation of septin and molecular motor recruitment in the microtubule environment of the taxol-resistant human breast cancer cell line MDA-MB-231[J]. Proteomics, 2011, 11(19):3877-3886. |
| [22] | Kavallaris M, Kuo DY, Burkhart CA, et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes[J]. J Clin Invest, 1997, 100(5):1282-1293. |
| [23] | Banerjee A. Increased levels of tyrosinated alpha-, beta(Ⅲ)-, and beta(Ⅳ)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells[J]. Biochem Biophys Res Commun, 2002, 293(1):598-601. |
| [24] | Tamura D, Arao T, Nagai T, et al. Slug increases sensitivity to tubulin-binding agents via the downregulation of βⅢ and βⅣα-tubulin in lung cancer cells[J]. Cancer Med, 2013, 2(2):144-154. |
| [25] | Kusel JR, McVeigh P, Thornhill JA. The schistosome excretory system: a key to regulation of metabolism, drug excretion and host interaction[J]. Trends Parasitol, 2009, 25(8):353-358. |
| [26] | Bahia D, Avelar LG, Vigorosi F, et al. The distribution of motor proteins in the muscles and flame cells of the Schistosoma mansoni miracidium and primary sporocyst[J]. Parasitology, 2006, 133(Pt 3):321-329. |
| [27] | Valverde-Islas LE, Arrangoiz E, Vega E, et al. Visualization and 3D reconstruction of flame cells of Taenia solium (Cestoda)[J]. PLoS One, 2011, 6(3):e14754. |
| [28] | Rohde K, Watson NA, Roubal FR. Ultrastructure of the protonephridial system of Anoplodiscus cirrusspiralis (Monogenea Monopisthocotylea)[J]. Int J Parasitol, 1992, 22(4):443-457. |
/
| 〈 |
|
〉 |